Singapore Exchange

<h1>Singapore Exchange</h1> <p>Listing-reform anchors: the Mainboard profit test became effective in <strong>October 2025</strong> (<code>october_2025_effective</code>) and uses consolidated <strong>pre-tax profit in the latest financial year</strong> (<code>pretax_profit_latest_fy</code>); the 2025 reforms moved toward <strong>consolidation toward SGX RegCo</strong> (<code>consolidation_toward_regco</code>) for listing-suitability and prospectus review while MAS retained statutory oversight (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS Equities Market Review</a>; <a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report</a>, accessed 16 August 2026).</p> <p>Singapore Exchange (SGX) is the integrated securities and derivatives exchange group through which companies list equity, trust, and bond instruments in Singapore, and through which investors trade shares, futures, foreign-exchange contracts, and commodity derivatives. Formed in 1999 by merging the Stock Exchange of Singapore and the Singapore International Monetary Exchange, SGX operates the trading platforms, the Central Depository clearing house, and Singapore Exchange Regulation (SGX RegCo), which acts as frontline regulator for listings and market conduct. The Monetary Authority of Singapore (MAS) remains the statutory capital-markets regulator under the Securities and Futures Act. SGX is therefore a market infrastructure institution at the centre of Singapore's <a href="/en/knowledge/article/sgkb.economy-finance.banking-and-financial-hub">financial hub</a> — distinct from banks, fund managers, and MAS itself, but essential to how capital is raised, priced, and transferred; dated SGX turnover, listing, REIT, and reform figures are maintained in <a href="/en/knowledge/dataset/sgkb.data.capital-markets-anchors">capital markets anchors</a>.</p> <h2>SGX Group structure and regulatory roles</h2> <p>SGX is not a single venue but a group of licensed entities under Singapore Exchange Limited, a company listed on its own Mainboard since 2000. The securities trading arm (SGX-ST) runs the cash equities market; the derivatives exchange (SGX-DT) lists futures and options; Central Depository (Pte) Limited (CDP) clears, settles, and holds securities; and SGX RegCo enforces listing rules and market conduct. MAS supervises the group under the Securities and Futures Act and related legislation, including the Exchanges (Demutualisation and Merger) Act 1999 that created the integrated exchange on 1 December 1999 (<a href="https://www.mas.gov.sg/regulation/acts/Exchanges-Demutualisation-and-Merger-Act">MAS, accessed Aug 2026</a>). This split matters for retrieval: SGX RegCo decides whether a company may list and whether disclosures meet rule requirements, while MAS sets capital-markets law, approves exchange licences, and retains statutory powers over prospectus registration and enforcement. Confusing the exchange operator with MAS leads to wrong answers about who licenses brokers or sets monetary policy (see <a href="/en/knowledge/article/sgkb.economy-finance.mas-and-monetary-policy">mas and monetary policy</a>).</p> <h2>Mainboard, Catalist, and market benchmarks</h2> <p>Singapore's listed equities trade on two boards with different admission philosophies. The Mainboard targets more established issuers and sets quantitative admission tests — including, since 29 October 2025, a profit test requiring consolidated pre-tax profit of at least S$10 million in the latest financial year, reduced from S$30 million under reforms recommended by MAS's Equities Market Review Group (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). Catalist, launched in 2007, is a sponsor-supervised board for growth companies: aspirant issuers engage an approved sponsor for due diligence and ongoing support, and Catalist does not impose the Mainboard's minimum profit threshold, though spread and governance requirements still apply. The benchmark Straits Times Index (STI) tracks large Mainboard constituents; in 2025 the STI closed at a record 4,655.38 on 30 December and delivered a 22.7% price return, or 28.8% with reinvested dividends, according to SGX market statistics (<a href="https://links.sgx.com/1.0.0/corporate-announcements/H3L2VGGP9YCWRZI2/">SGX, accessed Aug 2026</a>). STI-linked products remain a major share of cash-market turnover: STI constituent stocks accounted for about 80% of SGX securities trading value in 2025 (<a href="https://www.straitstimes.com/business/companies-markets/capital-markets-currencies/sgxs-securities-daily-average-value-2025-jumps-21-highest-2010">The Straits Times, accessed Aug 2026</a>).</p> <h2>Derivatives, FX, and commodities</h2> <p>SGX's derivatives franchise is often larger in contract volume than its cash equities market and serves regional hedging and investment demand beyond Singapore-listed shares. In 2025 derivatives volume across equities, foreign exchange, and commodities rose 10% to a record 329 million contracts; foreign-exchange futures volume reached 79.3 million contracts for the full year, also a record (<a href="https://links.sgx.com/1.0.0/corporate-announcements/H3L2VGGP9YCWRZI2/">SGX, accessed Aug 2026</a>). Flagship contracts include MSCI Singapore index futures (SiMSCI), China A50 and Nifty index products, USD/CNH FX futures, and iron ore derivatives — the iron ore suite recorded its seventh consecutive annual volume record in 2025 (<a href="https://www.straitstimes.com/business/companies-markets/capital-markets-currencies/sgxs-securities-daily-average-value-2025-jumps-21-highest-2010">The Straits Times, accessed Aug 2026</a>). This derivatives depth is a separate pillar of Singapore's capital-markets identity from domestic IPO activity: institutions use SGX to manage currency, commodity, and regional equity risk even when they do little business in Singapore-listed stocks.</p> <h2>Listing process and the disclosure-based shift</h2> <p>Until 2025, a Mainboard IPO typically required parallel review by SGX RegCo on listing suitability and by MAS on prospectus registration under Part 13 of the Securities and Futures Act — a dual-track process that issuers said lengthened time-to-market (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). MAS and SGX RegCo have since moved toward consolidating listing suitability and prospectus review under SGX RegCo for Mainboard listings, with MAS delegating prospectus lodgment and registration functions while retaining statutory oversight (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>). The broader policy direction is a more disclosure-based regime: lower prescriptive merit tests at admission, clearer ongoing disclosure obligations, and heavier reliance on market discipline, research coverage, and enforcement rather than ex-ante approval of business quality. Post-listing oversight has also been recalibrated — for example, SGX RegCo removed the Financial Watch List in October 2025 and shifted toward targeted queries and issuer announcements of sustained losses (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). Companies considering a Singapore listing still need sponsor or issue-manager support, audited financials, and continuous disclosure after listing; the reforms mainly reduce duplicated regulator engagement and align quantitative thresholds with other major exchanges.</p> <h2>Clearing, settlement, and how investors hold shares</h2> <p>Most Singapore retail investors hold SGX-listed securities through CDP direct accounts or broker accounts linked to CDP's book-entry system. CDP provides integrated clearing, settlement, and depository services — including dividend payments and corporate-action processing — so trades settle through the central counterparty rather than bilateral delivery between buyers and sellers (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). From 15 July 2026, rule changes allow depository agents to hold client securities in omnibus broker custody accounts, aligning with practice in several other markets and enabling brokers to offer portfolio services, fractional trading, and robo-advisory wrappers for local shares; retail investors may still keep direct CDP accounts if they prefer (<a href="https://links.sgx.com/FileOpen/20260701%20SGX%20custody%20structure%20enhancements%20to%20take%20effect%20from%20July%20board%20lot%20reduction%20in%20October.ashx?App=Announcement&amp;FileID=895053">SGX, accessed Aug 2026</a>). Trading mechanics are also changing: from 5 October 2026, the standard board lot for eligible instruments priced above S$10 and up to S$100 falls from 100 units to 10, and for instruments above S$100 from 100 units to 1, lowering minimum ticket sizes for high-priced bank and REIT counters (<a href="https://links.sgx.com/FileOpen/20260701%20SGX%20custody%20structure%20enhancements%20to%20take%20effect%20from%20July%20board%20lot%20reduction%20in%20October.ashx?App=Announcement&amp;FileID=895053">SGX, accessed Aug 2026</a>). Board lot size is a trading convention, not a separate securities law: brokerage and exchange fees still apply per transaction.</p> <h2>REITs, IPOs, and capital raising</h2> <p>Singapore is a major listing venue for real estate investment trusts (REITs) and property trusts. As of the fourth quarter of 2025, Singapore had 41 REITs and property trusts with combined market capitalisation of about S$104 billion, representing roughly 10% of overall listed equity market value (<a href="https://www.reitas.sg/wp-content/uploads/2026/03/SGX-Research-SREIT-Property-Trusts-Chartbook-Q4_2025.pdf">REITAS/SGX chartbook, accessed Aug 2026</a>). REIT issuance has driven recent IPO momentum: MAS reported that IPOs raised over S$2 billion in 2025, the strongest year since 2019, with REIT listings a major contributor alongside a handful of operating-company debuts (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>). The listing count nonetheless faces structural pressure — delistings have exceeded new listings in several recent years, and market participants continue to debate Catalist quality — so capital-raising headlines can improve even while the total number of listed securities drifts lower. Cross-border connectivity initiatives, including a proposed dual-listing bridge with Nasdaq for larger growth companies (market capitalisation from about S$2 billion) and a planned Global Listing Board with harmonised disclosure, aim to widen the issuer pipeline beyond purely domestic candidates (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>).</p> <h2>Market revitalisation and 2024–2026 reforms</h2> <p>From August 2024, MAS chaired an Equities Market Review Group to recommend demand- and supply-side measures after years of thin liquidity and weak small-cap participation relative to regional peers. Implemented and announced measures include a S$5 billion Equity Market Development Programme (EQDP) placing public-sector capital with selected fund managers to build Singapore-equity mandates — S$3.95 billion allocated across nine managers by November 2025 (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>); a S$30 million &quot;Value Unlock&quot; package for listed-company investor relations and strategy; GEMS research-grant enhancements; tax incentives for funds investing substantially in Singapore-listed equities; and trading-structure changes such as board-lot reduction and broker custody. Early indicators cited by MAS include average daily securities turnover of S$1.53 billion in the third quarter of 2025, up 16% year-on-year and the highest since the first quarter of 2021, and full-year 2025 securities daily average value of almost S$1.5 billion, up 21% and the highest since 2010 (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>; <a href="https://links.sgx.com/1.0.0/corporate-announcements/H3L2VGGP9YCWRZI2/">SGX, accessed Aug 2026</a>). Revitalisation is therefore a coordinated public-policy programme around SGX infrastructure, not a single rule change inside the exchange — and its success depends on sustained institutional and retail demand, not only on listing-rule liberalisation.</p> <h2>Reading a sharp market fall as a Singapore investor</h2> <p>A sharp fall in the Straits Times Index or an SGX-listed share is a market signal, not by itself a diagnosis of a company's solvency or a forecast of what happens next. Investors should first distinguish a broad market move from an issuer-specific announcement, and check the company's SGX announcements and financial statements rather than relying on social-media claims or a headline alone. The STI is a benchmark of large Mainboard stocks, not a measure of every Singapore-listed security or every investor's portfolio; an individual holding can move differently from the index. This is general information, not individual investment advice. MoneySense cautions that shares can lose substantial or all of their value, and that returns are not guaranteed (<a href="https://www.moneysense.gov.sg/guide-to-shares-what-you-need-to-know-before-you-invest/">MoneySense, accessed Nov 2026</a>).</p> <p>Market risk, liquidity risk and issuer risk are distinct. Market risk is the possibility that prices fall across a market; liquidity risk is difficulty selling at a reasonable price; issuer risk concerns the underlying company's financial position and prospects. A halt or suspension interrupts trading in the affected security under exchange rules; it does not reverse a loss or establish that the company is financially safe. Investors should check SGX's live market notices and the issuer's announcements for the reason and status of a halt. MoneySense identifies market and liquidity risks among the risks investors should understand; the <a href="/en/knowledge/article/sgkb.economy-finance.singapore-exchange">singapore exchange</a> rules and market notices govern individual securities (<a href="https://www.moneysense.gov.sg/investments/investment-risk/">MoneySense, accessed Nov 2026</a>; <a href="https://rulebook.sgx.com/rulebook/mainboard-rules">SGX Mainboard Rules, accessed Nov 2026</a>).</p> <p>For personal decisions, MoneySense recommends relating investments to goals, time horizon, available funds and risk profile; maintaining emergency savings and meeting near-term commitments before investing; and diversifying across asset classes, securities, industries or countries. Diversification can reduce concentration risk but cannot guarantee a profit or prevent losses when markets fall together. Dollar-cost averaging may reduce the risk of committing all funds at one price, but it does not remove market risk. These are planning concepts, not a rule to buy, hold or sell any particular SGX security (<a href="https://www.moneysense.gov.sg/investments/investment-portfolio/">MoneySense, accessed Nov 2026</a>; <a href="https://www.moneysense.gov.sg/investments/investment-risk/">MoneySense, accessed Nov 2026</a>).</p> <p>Sharp falls can also trigger behavioural traps: anchoring on one's purchase price, reacting to panic, trading too frequently, or mistaking a recent rebound for proof that risk has disappeared. A calmer review asks whether the original investment rationale or the issuer's circumstances have changed, whether the portfolio is too concentrated, whether borrowed money or leverage could force a sale, and when the cash is actually needed. MoneySense discusses these behavioural biases and stresses that responses depend on individual goals and circumstances (<a href="https://www.moneysense.gov.sg/investments/behavioural-science-and-investing/">MoneySense, accessed Nov 2026</a>). Investors who need personalised recommendations should consult an appropriately authorised financial adviser and verify the representative or institution through MAS's Financial Institutions Directory; beware of unsolicited investment offers and guaranteed high returns.</p>

简介

新加坡交易所

上市改革要点:主板盈利测试于 2025 年十月 (october_2025_effective) 生效,采用最近一个财年的合并税前利润 (pretax_profit_latest_fy);2025 年改革推动上市适格性审查和招股说明书审查逐步整合至 SGX RegCo (consolidation_toward_regco),同时由 MAS 保留法定监督权(MAS 股票市场检讨;MAS 最终报告,查阅日期:2026 年八月 16 日)。

新加坡交易所(SGX)是综合性证券及衍生品交易所集团,企业可通过该集团在新加坡上市股票、信托和债券工具,投资者则可通过该集团交易股票、期货、外汇合约和商品衍生品。SGX 于 1999 年由新加坡股票交易所和新加坡国际金融交易所合并成立,经营交易平台、中央存管结算机构,以及负责上市和市场行为一线监管的新加坡交易所监管公司(SGX RegCo)。新加坡金融管理局(MAS)仍依据《证券与期货法》担任法定资本市场监管机构。因此,SGX 是新加坡金融枢纽的核心市场基础设施机构——它有别于银行、基金管理公司和 MAS 本身,但对资本的筹集、定价和转移至关重要;有日期标注的 SGX 成交额、上市、房地产投资信托(REIT)和改革数据,收录于资本市场要点。

SGX 集团架构与监管职责

SGX 并非单一交易场所,而是新加坡交易所有限公司旗下的一组持牌实体;该公司自 2000 年起在自己的主板上市。证券交易部门(SGX-ST)经营现金股票市场;衍生品交易所(SGX-DT)挂牌期货和期权;中央存管私人有限公司(CDP)负责证券结算、交收和托管;SGX RegCo 执行上市规则和市场行为规范。MAS 根据《证券与期货法》及相关法规监管该集团,其中包括《1999 年交易所(非互助化与合并)法》;该法促成的综合交易所于 1999 年十二月 1 日成立(MAS,查阅日期:2026 年八月)。这种职责划分关系到信息检索:SGX RegCo 决定公司能否上市,以及披露是否符合规则要求;MAS 则制定资本市场法律、批准交易所牌照,并保留招股说明书注册和执法的法定权力。若把交易所运营方与 MAS 混为一谈,就会错误回答谁为经纪商发牌或谁制定货币政策(参见MAS 与货币政策)。

主板、凯利板与市场基准

新加坡上市股票在两个理念不同的板块交易。主板面向较成熟的发行人,并设有量化准入测试——其中,自 2025 年十月 29 日起,盈利测试要求最近一个财年的合并税前利润至少达到 10 百万新元;这一门槛低于 MAS 股票市场检讨小组改革建议出台前的 30 百万新元(MAS 最终报告,查阅日期:2026 年八月)。凯利板(Catalist)于 2007 年推出,是由保荐人监督、面向成长型公司的板块:有意发行人须聘请获批准的保荐人进行尽职调查并提供持续支持;凯利板不设主板的最低盈利门槛,但仍有公众持股分布和治理要求。海峡时报指数(STI)追踪大型主板成分股;根据 SGX 市场统计数据,2025 年 STI 于十二月 30 日以 4,655.38 点创收盘新高,价格回报率为 22.7%,计入再投资股息后为 28.8%(SGX,查阅日期:2026 年八月)。与 STI 挂钩的产品仍占现金市场成交额相当大的比重:2025 年 STI 成分股约占 SGX 证券交易价值的 80%(《海峡时报》,查阅日期:2026 年八月)。

衍生品、外汇与大宗商品

SGX 的衍生品业务按合约数量计算,往往大于其现金股票市场;它服务的区域对冲和投资需求也不限于新加坡上市股票。2025 年,股票、外汇和大宗商品衍生品成交量增长 10%,达到创纪录的 329 百万份合约;全年外汇期货成交量也创纪录,达到 79.3 百万份合约(SGX,查阅日期:2026 年八月)。旗舰合约包括 MSCI 新加坡指数期货(SiMSCI)、中国 A50 和 Nifty 指数产品、美元/离岸人民币外汇期货,以及铁矿石衍生品——铁矿石系列合约在 2025 年连续第七年创下年度成交量纪录(《海峡时报》,查阅日期:2026 年八月)。衍生品市场的深度,是新加坡资本市场特征中独立于本地 IPO 活动的一大支柱:即使机构很少交易新加坡上市股票,也会利用 SGX 管理货币、商品和区域股票风险。

上市流程与转向以披露为基础的制度

截至 2025 年,主板 IPO 通常须由 SGX RegCo 审查上市适格性,并由 MAS 根据《证券与期货法》第 13 部审查招股说明书注册——发行人表示,双轨流程延长了上市所需时间(MAS 最终报告,查阅日期:2026 年八月)。此后,MAS 和 SGX RegCo 已着手将主板上市适格性审查和招股说明书审查整合至 SGX RegCo,由 MAS 委托其负责招股说明书提交和注册职能,同时保留法定监督权(MAS,查阅日期:2026 年八月)。更广泛的政策方向是建立一个更多以披露为基础的制度:降低准入时过于规定性的实质审查要求,明确持续披露义务,并更多依靠市场纪律、研究覆盖和执法,而不是事前批准企业质量。上市后的监督也作了调整——例如,SGX RegCo 于 2025 年十月取消财务观察名单,改为针对性问询,并要求发行人公告持续亏损情况(MAS 最终报告,查阅日期:2026 年八月)。有意在新加坡上市的公司仍需要保荐人或发行经理支持、经审计财务报表,以及上市后的持续披露;改革主要旨在减少与监管机构重复接洽,并使量化门槛与其他主要交易所接轨。

结算、交收与投资者持股方式

大多数新加坡散户投资者通过 CDP 直接账户,或通过关联 CDP 记账系统的经纪账户持有 SGX 上市证券。CDP 提供综合结算、交收和存管服务,包括支付股息及处理公司行动,使交易通过中央对手方结算,而非买卖双方双边交付(MAS 最终报告,查阅日期:2026 年八月)。自 2026 年七月 15 日起,规则变更允许存管代理在经纪商综合托管账户中持有客户证券,使新加坡与多个其他市场的做法接轨,并让经纪商可为本地股票提供投资组合服务、碎股交易和机器人顾问服务;散户投资者如有需要,仍可保留 CDP 直接账户(SGX,查阅日期:2026 年八月)。交易机制也在变化:自 2026 年十月 5 日起,符合条件、价格高于 S$10 且不超过 S$100 的工具,其标准交易单位将从 100 股降至 10 股;价格高于 S$100 的工具,其标准交易单位将从 100 股降至 1 股,从而降低高价银行股和 REIT 的最低交易金额(SGX,查阅日期:2026 年八月)。标准交易单位是交易惯例,并非独立的证券法:经纪费和交易所费用仍按每笔交易收取。

REIT、IPO 与融资

新加坡是房地产投资信托(REIT)和房地产信托的重要上市地点。截至 2025 年第四季度,新加坡共有 41 个 REIT 和房地产信托,合计市值约 104 十亿新元,约占整体上市股票市场价值的 10%(REITAS/SGX 图表册,查阅日期:2026 年八月)。REIT 发行推动了近期 IPO 活动:MAS 报告称,2025 年 IPO 募资超过 2 十亿新元,是 2019 年以来表现最强的一年;REIT 上市是主要推动因素之一,另有少数运营公司的首次上市(MAS,查阅日期:2026 年八月)。不过,上市数量仍承受结构性压力——近年有好几年退市数量超过新上市数量,市场人士也持续讨论凯利板上市公司的质量。因此,即使融资消息有所改善,上市证券总数仍可能呈下降趋势。跨境互联举措,包括拟议中的纳斯达克双重上市通道(面向市值约 S$2 billion 起的较大型成长公司)和计划设立、披露规则协调一致的全球上市板,旨在拓宽发行人来源,使其不再局限于纯粹本地候选企业(MAS,查阅日期:2026 年八月)。

市场活化与 2024–2026 年改革

自 2024 年八月起,MAS 主持股票市场检讨小组,在多年流动性低迷、小型股参与度低于区域同业之后,提出需求侧和供给侧措施。已实施或公布的措施包括:规模为 5 十亿新元 的股票市场发展计划(EQDP),由公共部门资本拨付给指定基金管理公司,以建立新加坡股票投资委托;截至 2025 年十一月,已向九家管理公司拨款 3.95 十亿新元(MAS,查阅日期:2026 年八月);规模为 30 百万新元的“价值释放”配套计划,为上市公司投资者关系和战略提供支持;加强 GEMS 研究拨款;为主要投资新加坡上市股票的基金提供税务优惠;以及缩小标准交易单位和开放经纪商托管等交易结构调整。MAS 提到的早期指标包括:2025 年第三季度证券日均成交额为 1.53 十亿新元,同比增长 16%,为 2021 年第一季度以来最高;2025 全年证券日均成交额接近 1.5 十亿新元,增长 21%,为 2010 年以来最高(MAS,查阅日期:2026 年八月;SGX,查阅日期:2026 年八月)。因此,市场活化是围绕 SGX 基础设施展开的协调公共政策计划,并非交易所内部的一项单独规则变更;其成效取决于机构和散户需求能否持续,而不仅取决于上市规则放宽。

作为新加坡投资者如何看待市场大幅下跌

海峡时报指数或 SGX 上市股票大幅下跌,是一个市场信号,本身并不能诊断某家公司的偿付能力,也无法预测接下来会发生什么。投资者应先区分整体市场波动和发行人个别公告,并查阅公司在 SGX 发布的公告和财务报表,而不要只依赖社交媒体说法或单一新闻标题。STI 是大型主板股票的基准,并不代表每一只新加坡上市证券或每位投资者的投资组合;个别持仓的走势可能与指数不同。以上为一般信息,不构成针对个人的投资建议。新加坡金融教育局 MoneySense 提醒,股票可能大幅贬值甚至全部损失,回报也不受保证(MoneySense,查阅日期:2026 年十一月)。

市场风险、流动性风险和发行人风险各不相同。市场风险是指市场整体价格下跌的可能性;流动性风险是指难以按合理价格卖出的风险;发行人风险则涉及相关公司的财务状况和前景。根据交易所规则,停牌或暂停交易会中断相关证券的交易,但不会抵消损失,也不能证明公司财务安全。投资者应查阅 SGX 实时市场通知和发行人公告,了解停牌原因和状态。MoneySense 将市场风险和流动性风险列为投资者应了解的风险;新加坡交易所规则和市场通知适用于个别证券(MoneySense,查阅日期:2026 年十一月;SGX 主板规则,查阅日期:2026 年十一月)。

对于个人决策,MoneySense 建议根据目标、投资期限、可用资金和风险承受能力配置投资;在投资前保留应急储蓄并满足近期支出;并分散投资于不同资产类别、证券、行业或国家。分散投资可以降低集中风险,但不能保证获利,也不能避免市场同时下跌时的损失。定期定额投资可能降低一次性在某个价格投入全部资金的风险,但无法消除市场风险。这些是规划理念,并非买入、持有或卖出任何特定 SGX 证券的规则(MoneySense,查阅日期:2026 年十一月;MoneySense,查阅日期:2026 年十一月)。

市场大幅下跌也可能引发行为陷阱,例如执着于买入价、因恐慌而反应、过度频繁交易,或把近期反弹误认为风险已消失。较冷静的审视方式是思考:原有投资理由或发行人情况是否改变、投资组合是否过于集中、借款或杠杆是否可能迫使自己卖出,以及何时确实需要用到这笔现金。MoneySense 讨论了这些行为偏差,并强调应对方式取决于个人目标和情况(MoneySense,查阅日期:2026 年十一月)。需要个性化建议的投资者应咨询获得适当授权的财务顾问,并通过 MAS 金融机构名录核实代表或机构;谨防主动找上门的投资邀约,以及保证高回报的承诺。